-
Sarepta Therapeutics Inc. (SRPT $18.17)
- $18.17 Cap: $1.87B
- View SRPT Profile
- View Questions on SRPT
Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Sarepta Therapeutics Inc. (SRPT $18.17)
- $18.17 Cap: $1.87B
- View SRPT Profile
- View Questions on SRPT
Q: The IV on this stock is unreal. Its possible to do a short $70 put and $165 call for a profit of $15 if the price remains within those 2 strikes by November 24.
Obviously there are some major risks happening with the company. Do they have any clinical results or anything similar to that happening in the next 3-4 weeks that would cause such a high IV, to your knowlege?
Sheldon
Obviously there are some major risks happening with the company. Do they have any clinical results or anything similar to that happening in the next 3-4 weeks that would cause such a high IV, to your knowlege?
Sheldon
-
Sarepta Therapeutics Inc. (SRPT $18.17)
- $18.17 Cap: $1.87B
- View SRPT Profile
- View Questions on SRPT
-
Global Blood Therapeutics Inc. (GBT)
- Cap: $4.62B
- View GBT Profile
- View Questions on GBT
Q: Based on the research available to you, do you see reasonable upside potential for Global Blood and Sarepta? Would you choose one over the other? Do you see any major downside risks for either company? Thanks again for your support>
-
Sarepta Therapeutics Inc. (SRPT $18.17)
- $18.17 Cap: $1.87B
- View SRPT Profile
- View Questions on SRPT
Q: Can you provide an brief update about the stock, so you think it’s makes sense owning it ?
Thanks
Thanks
Insiders
Share Information
SEC Filings
News and Media